Opicapone (Ongentys) - a COMT inhibitor for Parkinson's disease.
Med Lett Drugs Ther
; 63(1615): 3-5, 2021 01 11.
Article
de En
| MEDLINE
| ID: mdl-33646998
Mots clés
Apokyn; Comtan; Inbrija; Kynmobi; Movapo; Nourianz; Ongentys; Parkinson's disease; Rytary; Stalevo; Tasmar; adverse effects; apomorphine; carbidopa/levodopa; dopamine; dosage; drug interactions; efficacy; entacapone; epinephrine; istradefylline; lactation; levodopa; opicapone; phenelzine; pregnancy; safety; selegeline; tolcapone
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Oxadiazoles
/
Maladie de Parkinson
/
Catechol O-methyltransferase
/
Inhibiteurs de la catéchol O-méthyltransférase
/
Antiparkinsoniens
Limites:
Humans
Langue:
En
Journal:
Med Lett Drugs Ther
Année:
2021
Type de document:
Article